Connect with us


How did cannabis companies perform this past week?

Cannabis stocks traded down this week despite a series of funding announcements and other good news, including a new bill from Congress. Canopy Growth Corp. (TSX:WEED) (NASDAQ:CGC) announced that Franchise Group Inc. (NASDAQ:FRG) subsidiary The Vitamin Shoppe will begin selling the entire collection of Martha Stewart CBD products, becoming the first national retailer to offer the full line.



GrowGeneration Corp. (NASDAQ: GRWG) is looking to raise $125 million via a public offering. The offer was increased to $150 million on Wednesday, with 5 million shares offered at $30.00 per share.

Weedmaps is going public via a merger with Silver Spike Acquisition Corp. (NASDAQ: SSPK), while LeafLink closed a $40 million Series C funding round led by Founders Fund.

“The money continues to flow into the cannabis sector, as we saw the huge $1.5 billion valuation that the Weedmaps deal with Silver Spike SPAC received. Not only that, GrowGeneration upped its offer from $125 million to $150 million. Despite the mixed stock performance, there is still a lot of demand for investing in this industry,” said Debra Borchard, editor-in-chief of the Green Market Report.

ETFMG Alternative Harvest ETF surpassed $1 billion in assets under management. The fund has been trading on the NYSE for less than three years and is the first cannabis-focused ETF listed in the United States. Jason Wilson, ETFMG Cannabis Research and Banking, said that “there are two key takeaways regarding MJ and the importance of reaching this milestone.”

Read the latest cannabis news and find more details about the cannabis industry with the mobile app.

The U.S. House of Representatives passed a bill to reduce barriers and expand scientific research on medical cannabis

According to Marijuana Business Daily, the bill will also allow for the private production and distribution of cannabis solely for research purposes.

Both the MORE Act and the Medical Marijuana Research Act are still awaiting a final decision in the Senate. Many experts believe the chances are slim that either bill will receive Senate approval, the report added.

In South Carolina, Republican lawmakers have prefiled a bill that would allow medical marijuana. Rep. Bill Herbkersman is the bill’s primary sponsor and attributes his support to his brother, who used cannabis to treat cancer-related symptoms.

Herbkersman said no one in South Carolina with a serious illness needs to skirt the law to get the relief they need.

“Waiting longer will only bring more suffering to those plagued by [a] debilitating disease,” he said, citing the availability of cannabis in 36 other states as another driver.

In Mexico, the country’s lower house of parliament opted to postpone debate on the cannabis legalization bill until February 2021. This is the third time the current deadline has been extended, following previous motions. Mexican senators passed the adult-use cannabis legalization bill on November 19th by a vote of 82 to 18.

What happened during the five trading days of the week

The ETFMG Alternative Harvest ETF (NYSE:MJ): lost 4.2%.

The AdvisorShares Pure Cannabis ETF (NYSE:YOLO): lost 4.3%.

The Cannabis ETF (NYSE:THCX): fell 7.9%.

The Amplify Seymour Cannabis ETF (NYSE:CNBS): fell 4.6%.

The SPDR S&P 500 ETF Trust (NYSE :SPY): fell 1.04%.

Canopy Growth Corp. (TSX:WEED) (NASDAQ:CGC) announced that Franchise Group Inc. (NASDAQ:FRG) subsidiary The Vitamin Shoppe will begin selling the entire collection of Martha Stewart CBD products, becoming the first national retailer to offer the full line.

The company later announced a new round of changes at its Canadian operations following a series of layoffs in April and September. The Smith Falls, Ontario-based company chose to close operations at its locations in St. John’s (Newfoundland and Labrador), Fredericton (New Brunswick), Edmonton (Alberta) and Bowmanville (Ontario).

The move would impact approximately 220 employees and “streamline operations and further improve margins,” Canopy noted. In addition, the company said it would also exit its Saskatchewan-based outdoor cannabis cultivation operation.

Jushi Holdings Inc. (CSE:JUSH) (OTCQB:JUSHF)’s retail brand Beyond/Hello partnered with Holistic Industries to help deliver “Garcia Hand Picked” to cannabis consumers in Santa Barbara.

Long-awaited cannabis products from Jay-Z’s Monogram cannabis line are finally available. Shawn ‘Jay-Z’ Carter’s Monogram cannabis line is the first brand created in partnership with Caliva, one of the largest vertically integrated cannabis companies in the country. Jay Z has been Caliva’s chief brand strategist since July 2019.

Rap artist T.I. is endorsing Georgia-based cannabis company Harvest Connect LLC. The Atlanta-born singer/songwriter, producer, record executive, and author has become an investor and equity partner in the company.

Cannabis tech company Dutchie has partnered with cannabis-focused branding agency Highopes to launch Flynt, a system designed to help small cannabis businesses build websites. Flynt touted as “the place for cannabis,” is said to be seamless and user-friendly. It offers pre-built templates to equip dispensaries with a cost-effective website so cannabis customers can opt for an e-commerce shopping experience.

The out-of-the-box solution also includes resources and best practice guidance from cannabis experts.

A report from New Frontier Data states that annual legal medical and recreational sales are estimated to grow at a compound annual growth rate (CAGR) of 21%, reaching more than $41 billion by 2025, up from $13.2 billion in 2019.

Other news of the week

Oscar-, Golden Globe- and Emmy-winning actress Nicole Kidman has been named the first strategic business partner and brand ambassador for The Sera Labs Inc. According to an update on Thursday, Kidman agreed to endorse the company’s current products. As the “face of the brand,” Kidman chose to support the product development efforts of Los Angeles-based CBD Products.

Venom Extracts, which is owned by Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRF) owned, generated $31.4 million (CA$40 million) in sales year to date. This is the second and final revenue milestone Venom has reached under the acquisition agreement the company signed in March. Recall how Hollister paid $15.7 million (CA$20 million) for the Arizona-based cannabis extract brand. Venom also reported a positive adjusted EBITDA of $3.8 million (CA$4.8 million).

Hemp and cannabis infusion technology company Vertosa began offering a proprietary powder-based emulsion powder formulated to infuse CBD into a range of product categories, from supplements to tea and coffee pods to protein bars, for fast-acting potency and consistent potency.

PharmaCielo (TSXV: PCLO) (OTCQX: PCLOF) partnered with U.S.-based AssuredTrans to provide independent laboratory testing and analysis for the product quality of PharmaCielo’s CBD extracts in the United States.

Sundial Growers Inc. (NASDAQ: SNDL) received approval to transfer its listing to the Nasdaq Capital Market. The transfer is expected to be effective December 15th.

Power REIT (AMEX:PW), an infrastructure-focused real estate investment trust, purchased a 2.11-acre property in Crowley County, Colorado, for $1.3 million. The deal also includes Power REIT’s assistance in building an 18,528-square-foot greenhouse and processing facility.

Red White & Bloom Brands Inc.(CSE:RWB) (OTCQX:RWBYF) launched an exclusive line of High Times brand cannabis products in Michigan. Provisioning centers can now place pre-orders.

Pure Extracts Technologies Corp.(CSE:PULL) decided to join the growing mushroom industry through a collaboration with The Nutraceutical Medicine Company Inc.

Icanic Brands Inc. (CSE: ICAN) (OTCQB: ICNAF), the company behind Tarantula, announced its intention to buy THC Engineering LLC for $1.75 million.


(Featured image by David Gabric via Unsplash)

DISCLAIMER: This article was written by a third party contributor and does not reflect the opinion of Born2Invest, its management, staff or its associates. Please review our disclaimer for more information.

This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.

First published in finanz trends, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.

Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Born2Invest assumes no responsibility for errors, omissions or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Born2Invest is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.

Sharon Harris is a feminist and a part-time nomad. She reports about businesses primarily involved in tech, CBD, and crypto. She started her career as a product manager at a Silicon Valley startup but now enjoys a new life as a personal finance geek and writer. Her primary aim is to provide readers with a new perspective on the overlapping world of finance and technology.